Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate

Mostrar otras versiones (1)

Zuclopenthixol is available in two parenteral formulation,i.e., in the form of acetate and decanoate. It has high affinity for dopamine D1 and D2 receptors. There is limited literature of association of neuroleptic malignant syndrome with the use of zuclopenthixol monotherapy. These case reports hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Shouan, Anish, Sinha, Ankit Kumar, Grover, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989464/
https://www.ncbi.nlm.nih.gov/pubmed/33776291
http://dx.doi.org/10.4103/ipj.ipj_54_19
_version_ 1783668943808888832
author Shouan, Anish
Sinha, Ankit Kumar
Grover, Sandeep
author_facet Shouan, Anish
Sinha, Ankit Kumar
Grover, Sandeep
author_sort Shouan, Anish
collection PubMed
description Zuclopenthixol is available in two parenteral formulation,i.e., in the form of acetate and decanoate. It has high affinity for dopamine D1 and D2 receptors. There is limited literature of association of neuroleptic malignant syndrome with the use of zuclopenthixol monotherapy. These case reports have mostly implicated zuclopenthixol decanoate, and also zuclopenthixol acetate. In this report, we present a case of neuroleptic malignant syndrome associated with use of zuclopenthixol acetate.
format Online
Article
Text
id pubmed-7989464
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-79894642021-03-26 Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate Shouan, Anish Sinha, Ankit Kumar Grover, Sandeep Ind Psychiatry J Case Report Zuclopenthixol is available in two parenteral formulation,i.e., in the form of acetate and decanoate. It has high affinity for dopamine D1 and D2 receptors. There is limited literature of association of neuroleptic malignant syndrome with the use of zuclopenthixol monotherapy. These case reports have mostly implicated zuclopenthixol decanoate, and also zuclopenthixol acetate. In this report, we present a case of neuroleptic malignant syndrome associated with use of zuclopenthixol acetate. Wolters Kluwer - Medknow 2020 2020-11-07 /pmc/articles/PMC7989464/ /pubmed/33776291 http://dx.doi.org/10.4103/ipj.ipj_54_19 Text en Copyright: © 2020 Industrial Psychiatry Journal http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Shouan, Anish
Sinha, Ankit Kumar
Grover, Sandeep
Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate
title Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate
title_full Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate
title_fullStr Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate
title_full_unstemmed Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate
title_short Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate
title_sort neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989464/
https://www.ncbi.nlm.nih.gov/pubmed/33776291
http://dx.doi.org/10.4103/ipj.ipj_54_19
work_keys_str_mv AT shouananish neurolepticmalignantsyndromeassociatedwiththeuseofinjectionzuclopenthixolacetate
AT sinhaankitkumar neurolepticmalignantsyndromeassociatedwiththeuseofinjectionzuclopenthixolacetate
AT groversandeep neurolepticmalignantsyndromeassociatedwiththeuseofinjectionzuclopenthixolacetate

Ejemplares similares